title: Nilotinib versus imatinib for GIST.
authors.affiliation: Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Paul
authors.initials: P
authors.lastname: Gougis
authors.affiliation: Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Angelo
authors.initials: A
authors.lastname: Paci
authors.affiliation: University Paris Descartes Cochin Teaching Hospital, Paris, France.
authors.forename: Romain
authors.initials: R
authors.lastname: Coriat
authors.affiliation: University Paris Descartes INSERM CIC1419, Paris, France.
authors.forename: Saik
authors.initials: S
authors.lastname: Urien
authors.affiliation: Gustave Roussy Cancer Campus, Villejuif, France; University Paris Descartes INSERM CIC1419, Paris, France. Electronic address: olivier.mir@gustaveroussy.fr.
authors.forename: Olivier
authors.initials: O
authors.lastname: Mir
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001549:Benzamides / Q000008:administration & dosage*; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines